Altibi Ahmed M, Prousi George, Agarwal Manyoo, Shah Mahek, Tripathi Byomesh, Ram Pradhum, Patel Brijesh
Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
Henry Ford Allegiance Health, Jackson, MI, USA.
Heart Fail Rev. 2021 Jan;26(1):57-64. doi: 10.1007/s10741-019-09912-z.
The 30-day readmission rates, predictors, and outcomes for acute heart failure (AHF) patients are well published, but data beyond 30 days and the association between readmission-free period (RFP) and in-hospital readmission-related mortality remain unknown. We queried the National Readmission Database to analyze comparative outcomes of AHF. Patients were divided into three groups based on their RFP: group 1 (1-30 days), group 2 (31-90 days), and group 3 (91-275 days). AHF cases and clinical variables were identified using ICD-9 codes. The primary outcome was in-hospital mortality at the time of readmission. A total of 39,237 unplanned readmissions occurred within 275 days; 15,181 within group 1, 11,925 within group 2, and 12,131 within group 3. In-hospital mortality in groups 1, 2, and 3 were 7.4%, 5.1%, and 4.1% (p < 0.001). Group 1 had higher percentages of patients with cardiogenic shock (1.3% vs. 0.9% vs. 0.9%; p < 0.001), acute kidney injury (30.2% vs. 25.9% vs. 24.0%; p < 0.001), dialysis use (8.6% vs. 7.5% vs. 6.9%; p < 0.001), and non-ST elevation myocardial infarction (4.4% vs. 3.8% vs. 3.6%; p < 0.001), but there was no statistical difference among the three groups for ST-elevation myocardial infarction, percutaneous coronary intervention (PCI), or ventricular assist device use at the time of index admission. However, group 3 had higher PCI (1.7%) compared with groups 1 and 2 (p < 0.001). In multivariable logistic regression, groups 2 and 3 had odd ratio of 0.70 and 0.55, respectively, for in-hospital mortality compared with group 1. Longer RFP is associated with decreased risk of in-hospital mortality at the time of first readmission.
急性心力衰竭(AHF)患者的30天再入院率、预测因素及预后已有大量报道,但30天以上的数据以及无再入院期(RFP)与住院再入院相关死亡率之间的关联尚不清楚。我们查询了国家再入院数据库以分析AHF的比较结果。根据患者的RFP将其分为三组:第1组(1 - 30天)、第2组(31 - 90天)和第3组(91 - 275天)。使用ICD - 9编码识别AHF病例和临床变量。主要结局是再入院时的住院死亡率。在275天内共发生39237次非计划再入院;第1组15181次,第2组11925次,第3组12131次。第1、2、3组的住院死亡率分别为7.4%、5.1%和4.1%(p < 0.001)。第1组心源性休克患者比例更高(1.3%对0.9%对0.9%;p < 0.001)、急性肾损伤患者比例更高(30.2%对25.9%对24.0%;p < 0.001)、透析使用率更高(8.6%对7.5%对6.9%;p < 0.001)以及非ST段抬高型心肌梗死患者比例更高(4.4%对3.8%对3.6%;p < 0.001),但在首次入院时,三组在ST段抬高型心肌梗死、经皮冠状动脉介入治疗(PCI)或心室辅助装置使用方面无统计学差异。然而,第3组的PCI使用率(1.7%)高于第1组和第2组(p < 0.001)。在多变量逻辑回归分析中,与第1组相比,第2组和第3组住院死亡率的比值比分别为0.70和0.55。更长的RFP与首次再入院时住院死亡率风险降低相关。